Welcome to the e-CCO Library Archive!
Abstract 7: IBD phenotypes differ in gut microbiota composition
Presentation - ECCO 2016 Amsterdam Congress - 2nd Y-ECCO Basic Science Workshop: Session 2: Studying the microbiota in IBD (Keywords: IBD, CD, UC, Mycobiota, immune response)
Lukas Bajer
ACCURE/PASSION (Appendectomy for UC)
Presentation - ECCO 2015 Barcelona Congress - 4th S-ECCO IBD Masterclass Session 2: “The technique” (Keywords: clinical trials, IBD, UC, appendectomy)
Saloomeh Sahami
Active comparators – End of placebo?
Presentation - ECCO 2015 Barcelona Congress - 4th ClinCom Workshop Session 1: What’s next in IBD drug development?
Melchiorri Daniela
Activity in IBD
Presentation - ECCO 2016 Amsterdam Congress - 1st H-ECCO IBD Masterclass: Session 4: Special situations (Keywords: activity indices, IBD, UC, CD, histology)
Paula Borralho
Acute presentation: New UC or non-IBD colitis?
Presentation - ECCO 2013 Vienna Congress - Scientific session 1: Early stage IBD
Peter Irving
Adherence
Presentation - ECCO 2015 Barcelona Congress - 6th N-ECCO School Session 1: Diagnosis and assessment (5-aminosalicylate, 5-ASA, mercaptopurine, adalimumab, AZA, budesonide, calprotectin, certolizumab, IBD, CD, UC, immunosuppressive agents, infliximab, mesalamine, 5-aminosalicylic acid, methotrexate, monitoring, smoking)
Bager Palle
Adherence
Presentation - ECCO 2016 Amsterdam Congress - 7th N-ECCO School: Session 1: Diagnosis and assessment (Keywords: adherence)
Palle Bager
Advancement plasty for Crohns fistula
Presentation - ECCO 2016 Amsterdam Congress - 5th S-ECCO IBD Masterclass: Session 1: Perianal disease (Keywords: fistula, CD, advancement flap)
Zuzana Serclova
Algorithm for abdominal pain management
Presentation - ECCO 2015 Barcelona Congress - Scientific session 11: Managing the manageable: Chronic pain and fatigue (Keywords: complications, disease activity, disease outcome, IBD, CD, UC)
Andreas Sturm
Algorithm for the management of fatigue
Presentation - ECCO 2015 Barcelona Congress - Scientific session 11: Managing the manageable: Chronic pain and fatigue (Keywords: fatigue, IBD)
Janneke Van der Woude
Alternative techniques: Kock’s pouch and ileorectal anastomosis
Presentation - ECCO 2013 Vienna Congress - 2nd S-ECCO IBD Masterclass - Session 2: The ileoanal pouch
Francesco Tonelli
Anatomy and physiology of the GI tract – Pathophysiology of IBD
Presentation - ECCO 2013 Vienna Congress - 4th N-ECCO School - Session 1: Diagnosis and assessment
Marian O'Connor
Anatomy and physiology of the GI tract – Pathophysiology of IBD
Presentation - ECCO 2014 Copenhagen Congress - 5th N-ECCO School - Session 1: Diagnosis and assessment: Anatomy and physiology of the GI tract – Pathophysiology of IBD
Marian O’Connor
Animal models in IBD: Pros and cons
Presentation - ECCO 2016 Amsterdam Congress - 2nd Y-ECCO Basic Science Workshop: Session 1: Mouse models in IBD (Keywords: biologic treatment, endoscopic assessment)
Markus Neurath
Announcement of ECCO Fellowship & Grants 2016
Presentation - ECCO 2016 Amsterdam Congress - Scientific session 7: ECCO Fellowships & Grants
Gerhard Rogler
Announcement of ECCO Fellowships and Grants 2012
Closed Website Area - Congress 2012 Recordings
Andreas Sturm
Announcement of ECCO Fellowships and Grants 2013
Presentation - ECCO 2013 Vienna Congress – Scientific session 7: ECCO Fellowships and Grants
Andreas Stum
Appendectomy
Presentation - ECCO 2016 Amsterdam Congress - 3rd EpiCom Workshop: Session 1 (Keywords: IBD, CD, UC, IBDQ, mesalamine, 5-aminosalicylic acid, MMX, eHealth, feacal calprotectin, compliance)
Pia Munkholm
Applying pharmacockinetics in the daily care of patients: From combination therapy to therapeutic drug monitoring
Presentation - ECCO 2015 Barcelona Congress - Scientific session 2: Pharmacokinetics in clinical practice (Keywords: IBD, CD, UC, pharmacokinetics, trough levels)
Barrett Levesque
Approval pathways (differences between EMA and FDA, extrapolating data across indications)
Presentation - ECCO 2014 Copenhagen Congress - 3rd ClinCom Workshop: Session I: Biosimilars: Are we ready to change?: Approval pathways (differences between EMA and FDA, extrapolating data across indications) (Keywords: anti-TNF, biologic treatment, IBD, infliximab, pharmacogenomics, drug approval, similar biological medicinal product, relecant animal model, clinical studies, clinical endpoints, safety, immunogenicity, extrapolation)
Elmer Schabel